454 related articles for article (PubMed ID: 12925683)
1. The enigma of sepsis.
Riedemann NC; Guo RF; Ward PA
J Clin Invest; 2003 Aug; 112(4):460-7. PubMed ID: 12925683
[TBL] [Abstract][Full Text] [Related]
2. Novel strategies for the treatment of sepsis.
Riedemann NC; Guo RF; Ward PA
Nat Med; 2003 May; 9(5):517-24. PubMed ID: 12724763
[TBL] [Abstract][Full Text] [Related]
3. Complement-related molecular events in sepsis leading to heart failure.
Hoesel LM; Niederbichler AD; Ward PA
Mol Immunol; 2007 Jan; 44(1-3):95-102. PubMed ID: 16875736
[TBL] [Abstract][Full Text] [Related]
4. [Advances in research of the roles of C5a-C5L2, high mobility group B1 and Toll like receptor 4 in sepsis].
Fang Y; Li C
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 Feb; 27(2):155-7. PubMed ID: 25665619
[No Abstract] [Full Text] [Related]
5. Pulmonary inflammation--a balancing act.
Colten HR; Krause JE
N Engl J Med; 1997 Apr; 336(15):1094-6. PubMed ID: 9091809
[No Abstract] [Full Text] [Related]
6. Expression of functional receptors for human C5a anaphylatoxin (CD88) on the human hepatocellular carcinoma cell line HepG2. Stimulation of acute-phase protein-specific mRNA and protein synthesis by human C5a anaphylatoxin.
Buchner RR; Hugli TE; Ember JA; Morgan EL
J Immunol; 1995 Jul; 155(1):308-15. PubMed ID: 7541417
[TBL] [Abstract][Full Text] [Related]
7. Complement C5a anaphylatoxin fragment causes apoptosis in TGW neuroblastoma cells.
Farkas I; Baranyi L; Liposits ZS; Yamamoto T; Okada H
Neuroscience; 1998 Oct; 86(3):903-11. PubMed ID: 9692726
[TBL] [Abstract][Full Text] [Related]
8. Neutrophil C5a receptor and the outcome in a rat model of sepsis.
Guo RF; Riedemann NC; Bernacki KD; Sarma VJ; Laudes IJ; Reuben JS; Younkin EM; Neff TA; Paulauskis JD; Zetoune FS; Ward PA
FASEB J; 2003 Oct; 17(13):1889-91. PubMed ID: 12897064
[TBL] [Abstract][Full Text] [Related]
9. A key role of C5a/C5aR activation for the development of sepsis.
Riedemann NC; Guo RF; Ward PA
J Leukoc Biol; 2003 Dec; 74(6):966-70. PubMed ID: 12960283
[TBL] [Abstract][Full Text] [Related]
10. The dark side of C5a in sepsis.
Ward PA
Nat Rev Immunol; 2004 Feb; 4(2):133-42. PubMed ID: 15040586
[TBL] [Abstract][Full Text] [Related]
11. C5a receptor and thymocyte apoptosis in sepsis.
Riedemann NC; Guo RF; Laudes IJ; Keller K; Sarma VJ; Padgaonkar V; Zetoune FS; Ward PA
FASEB J; 2002 Jun; 16(8):887-8. PubMed ID: 12039868
[TBL] [Abstract][Full Text] [Related]
12. The role of complement, C5a and its receptors in sepsis and multiorgan dysfunction syndrome.
Flierl MA; Schreiber H; Huber-Lang MS
J Invest Surg; 2006; 19(4):255-65. PubMed ID: 16835140
[TBL] [Abstract][Full Text] [Related]
13. The C terminus of the human C5a receptor (CD88) is required for normal ligand-dependent receptor internalization.
Bock D; Martin U; Gärtner S; Rheinheimer C; Raffetseder U; Arseniev L; Barker MD; Monk PN; Bautsch W; Köhl J; Klos A
Eur J Immunol; 1997 Jun; 27(6):1522-9. PubMed ID: 9209506
[TBL] [Abstract][Full Text] [Related]
14. Solution structure of a unique C5a semi-synthetic antagonist: implications in receptor binding.
Zhang X; Boyar W; Galakatos N; Gonnella NC
Protein Sci; 1997 Jan; 6(1):65-72. PubMed ID: 9007977
[TBL] [Abstract][Full Text] [Related]
15. C3a and C5a are chemotaxins for human mast cells and act through distinct receptors via a pertussis toxin-sensitive signal transduction pathway.
Nilsson G; Johnell M; Hammer CH; Tiffany HL; Nilsson K; Metcalfe DD; Siegbahn A; Murphy PM
J Immunol; 1996 Aug; 157(4):1693-8. PubMed ID: 8759757
[TBL] [Abstract][Full Text] [Related]
16. In U-937 promonocytes, misteltoe lectin I increases basal [Ca2+]i, enhances histamine H1- and complement C5a-receptor-mediated rises in [Ca2+]i, and induces cell death.
Wenzel-Seifert K; Lentzen H; Seifert R
Naunyn Schmiedebergs Arch Pharmacol; 1997 Feb; 355(2):190-7. PubMed ID: 9050011
[TBL] [Abstract][Full Text] [Related]
17. rC5a directs the in vitro migration of human memory and naive tonsillar B lymphocytes: implications for B cell trafficking in secondary lymphoid tissues.
Ottonello L; Corcione A; Tortolina G; Airoldi I; Albesiano E; Favre A; D'Agostino R; Malavasi F; Pistoia V; Dallegri F
J Immunol; 1999 Jun; 162(11):6510-7. PubMed ID: 10352266
[TBL] [Abstract][Full Text] [Related]
18. Sepsis under siege: a new understanding of sepsis might lead to the development of therapies to treat septic shock.
Hunter P
EMBO Rep; 2006 Jul; 7(7):667-9. PubMed ID: 16819459
[No Abstract] [Full Text] [Related]
19. The chemotactic receptor for human C5a anaphylatoxin.
Gerard NP; Gerard C
Nature; 1991 Feb; 349(6310):614-7. PubMed ID: 1847994
[TBL] [Abstract][Full Text] [Related]
20. Protection of innate immunity by C5aR antagonist in septic mice.
Huber-Lang MS; Riedeman NC; Sarma JV; Younkin EM; McGuire SR; Laudes IJ; Lu KT; Guo RF; Neff TA; Padgaonkar VA; Lambris JD; Spruce L; Mastellos D; Zetoune FS; Ward PA
FASEB J; 2002 Oct; 16(12):1567-74. PubMed ID: 12374779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
